MongoDB shares slide 28% as forward guidance disappoints despite Q4 beat

MongoDB (MDB) is down 28.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The sell-off appears tied to MongoDB’s forward guidance coming in a bit light versus what investors were positioned for, even though quarterly results beat estimates. A modest deceleration in key cloud growth metrics also likely amplified concerns about near-term demand and spending momentum.

Details:

MongoDB’s quarterly results topped expectations, with adjusted EPS of $1.65 and revenue of $695 million.

For the next quarter, MongoDB guided adjusted EPS of $1.15–$1.19, slightly below consensus expectations, alongside revenue of $659–$664 million (roughly in line).

Growth in Atlas (its cloud database offering) was around 29% year over year, a slight deceleration from the prior quarter and potentially below what the market was pricing in.

In its earnings release, MongoDB also disclosed a leadership update, naming Erica Volini as Chief Customer Officer effective March 3, 2026.

Sources:

PR Newswire, Barron’s, Investor’s Business Daily

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MDB Insider Trading Activity

$MDB insiders have traded $MDB stock on the open market 75 times in the past 6 months. Of those trades, 0 have been purchases and 75 have been sales.

Here’s a breakdown of recent trading of $MDB stock by insiders over the last 6 months:

DWIGHT A MERRIMAN has made 0 purchases and 43 sales selling 123,583 shares for an estimated $44,378,010.
ROELOF BOTHA has made 0 purchases and 11 sales selling 24,850 shares for an estimated $10,085,418.
PETER THOMAS KILLALEA has made 0 purchases and 8 sales selling 20,000 shares for an estimated $6,437,452.
HOPE F COCHRAN has made 0 purchases and 3 sales selling 3,740 shares for an estimated $1,455,636.
CHARLES M JR HAZARD has made 0 purchases and 8 sales selling 3,996 shares for an estimated $1,330,398.
THOMAS BULL (Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,555 shares for an estimated $555,942.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MDB Hedge Fund Activity

We have seen 497 institutional investors add shares of $MDB stock to their portfolio, and 433 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,980,978 shares (-77.5%) from their portfolio in Q4 2025, for an estimated $1,670,776,656
MORGAN STANLEY removed 1,338,682 shares (-49.2%) from their portfolio in Q4 2025, for an estimated $561,831,448
AMUNDI removed 1,163,837 shares (-78.5%) from their portfolio in Q4 2025, for an estimated $488,450,750
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 825,895 shares (+229.1%) to their portfolio in Q4 2025, for an estimated $346,619,872
BLACKROCK, INC. added 799,661 shares (+16.0%) to their portfolio in Q4 2025, for an estimated $335,609,725
FIL LTD removed 712,218 shares (-59.9%) from their portfolio in Q4 2025, for an estimated $298,910,772
VALUEACT HOLDINGS, L.P. removed 711,400 shares (-33.6%) from their portfolio in Q4 2025, for an estimated $298,567,466

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$MDB Congressional Stock Trading

Members of Congress have traded $MDB stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MDB stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 3 purchases worth up to $45,000 on 11/18, 10/17, 09/12 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$MDB Analyst Ratings

Wall Street analysts have issued reports on $MDB in the last several months. We have seen 19 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 01/20/2026
RBC Capital issued a "Outperform" rating on 01/05/2026
Argus Research issued a "Buy" rating on 12/04/2025
Piper Sandler issued a "Overweight" rating on 12/02/2025
Oppenheimer issued a "Outperform" rating on 12/02/2025
Canaccord Genuity issued a "Buy" rating on 12/02/2025
DA Davidson issued a "Buy" rating on 12/02/2025

To track analyst ratings and price targets for $MDB, check out Quiver Quantitative's $MDB forecast page.

$MDB Price Targets

Multiple analysts have issued price targets for $MDB recently. We have seen 30 analysts offer price targets for $MDB in the last 6 months, with a median target of $431.5.

Here are some recent targets:

Matthew Broome from Mizuho set a target price of $290.0 on 03/03/2026
Blair Abernethy from Rosenblatt set a target price of $385.0 on 03/03/2026
Ittai Kidron from Oppenheimer set a target price of $375.0 on 03/03/2026
Patrick Colville from Scotiabank set a target price of $275.0 on 03/03/2026
Firoz Valliji from Bernstein set a target price of $428.0 on 03/03/2026
Mike Cikos from Needham set a target price of $300.0 on 03/03/2026
William Power from Baird set a target price of $260.0 on 03/03/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.